MART-1/Melan-A and tyrosinase transcripts in peripheral blood of melanoma patients: PCR analyses and follow-up testing in relation to clinical stage and disease progression

Melanoma Research

Volumn 11, Issue 5, 2001, Pages 543-548

  Strohal, R ^a   Mosser, R ^a   Kittler, H ^a   Wolff, K ^a   Jansen, B ^a   Brna, C ^a   Stingl, G ^a   Pehamberger, H ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

Author keywords

MART 1; Melanoma; Metastatic disease; Molecular marker; Tyrosinase

Indexed keywords

MELAN A; MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; MELANOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROCONVERSION; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; RNA STABILITY; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 0034780881     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200110000-00016     Document Type: Article

References (15)

1. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction
2. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients
3. Detection and quantification of melanoma cells in the circulation of patients
4. Detection of tyrosinase mRNA from the blood of melanoma patients
5. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression
6. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: A clinical two-center study
7. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: Evaluation strategy and correlation with known prognostic markers in 123 melanoma patients
8. Melanoma-associated antigens as messenger RNA detection markers for melanoma
9. Polymerase chain reaction detection of melanoma cells in the circulation: Relation to clinical stage, surgical treatment, and recurrences from melanoma
10. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: A quality control study using real-time quantitative RT-PCR
11. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus
12. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor
13. First comparative delineation of the T-cell receptor repertoire in primary and multiple subsequent/coexisting metastatic melanoma sites
14. Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo